Clinical Trials Browser

Withdrawn × durvalumab × Genitourinary × Clear all

NCT04262375 2020-11-17

DOMINATION

Phase 2 Withdrawn

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell

NCT04073160 2020-07-07

TRIO Bladder

Phase 1 Withdrawn

Urinary Bladder Neoplasms